<DOC>
	<DOCNO>NCT01418859</DOCNO>
	<brief_summary>The purpose research evaluate effect additional chemotherapy postoperation therapy cervical cancer patient risk factor ( big tumor , deep invasion tumor thrombus vascular system ) .</brief_summary>
	<brief_title>Clinical Study Post-operation Treatment Cervical Cancer</brief_title>
	<detailed_description>Cervical cancer high morbidity . Many patient need additional therapy surgery order elevate survival rate life quality . In research , go give additional therapy patient big tumor , deep invasion tumor thrombus vascular system surgery . randomize control method use research , order compare survival rate side effect radiation therapy , concurrent chemoradiotherapy , concurrent chemoradiotherapy additional chemotherapy . 3D-CRT Topotecan use research .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>1. patient underwent cervical cancer radical surgery three month higt risk factor include deep stromal invasion , large primary tumour and/or lymphovascular spase invasion ; 2. squamous carcinoma ; 3. ageï¼œ70 ; 4 . Gynecologic Oncology Group ( GOG ) :02 . 1. negative node , surgical margin , and/or parametrium ; 2 . No serious damage liver kidney function , hypertension , diabetes effect therapy complication .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>postoperation</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiotherapy</keyword>
</DOC>